Recommended Topic Related To:

Vira-A

"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.

Dotarem is a gadolinium-based"...

Vira-A

Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

Vira-A Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Vira-A (vidarabine monohydrate) Ophthalmic Ointment is an antiviral medication used to treat eye infections caused by the herpes virus. The brand name of this medication is discontinued, but generic versions may be available. Common side effects include burning, stinging, pain, irritation, itching, redness, blurred vision, tearing, or sensitivity to light.

Administer approximately one-half inch of Vira-A Ophthalmic Ointment, 3%, into the lower conjunctival sac five times daily at three-hour intervals. Vira-A may interact with other eye medications. Tell your doctor all medications and supplements you use. It is unknown if Vira-A ophthalmic will harm a fetus. Tell your doctor if you are pregnant. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Our Vira-A (vidarabine monohydrate) Ophthalmic Ointment Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Vira-A FDA Prescribing Information: Side Effects
(Adverse Reactions)

SIDE EFFECTS

Lacrimation, foreign body sensation, conjunctival injection, burning, irritation, superficial punctate keratitis, pain, photophobia, punctal occlusion, and sensitivity have been reported with VIRA-A (vidarabine) Ophthalmic Ointment, 3%. The following have also been reported but appear disease-related: uveitis, stromal edema, secondary glaucoma, trophic defects, corneal vascularization, and hyphema.

Read the entire FDA prescribing information for Vira-A (Vidarabine) »

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.